|
| [March 08, 2013] |
 |
Research and Markets: Alopecia Global Clinical Trials Review, H1, 2013
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/fvvwh5/alopecia_global)
has announced the addition of GlobalData's new report "Alopecia Global
Clinical Trials Review, H1, 2013" to their offering.
Our clinical trial report, Alopecia Global Clinical Trials Review, H1,
2013" provides data on the Alopecia clinical trial scenario. This report
provides elemental information and data relating to the clinical trials
on Alopecia. It includes an overview of the trial numbers and their
recruitment status as per the site of trial conduction across the globe.
The databook offers a preliminary coverage of disease clinical trials by
their phase, trial tatus, prominence of the sponsors and also provides
briefing pertaining to the number of trials for the key drugs for
treating Alopecia. This report is built using data and information
sourced from proprietary databases, primary and secondary research and
in-house analysis by Our team of industry experts.
Scope
- Data on the number of clinical trials conducted in North America,
South and Central America, Europe, Middle-East and Africa and
Asia-pacific and top five national contributions in each, along with the
clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status,
subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed
manner
- Abridged view of the performance of the trials in terms of their
status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes /
Hospitals or Companies
For more information visit http://www.researchandmarkets.com/research/fvvwh5/alopecia_global
Source (News - Alert): GlobalData

[ Back To Technology News's Homepage ]
|